Appili Therapeutics Stock Market Value

APLI Stock  CAD 0.04  0.00  0.00%   
Appili Therapeutics' market value is the price at which a share of Appili Therapeutics trades on a public exchange. It measures the collective expectations of Appili Therapeutics investors about its performance. Appili Therapeutics is selling at 0.035 as of the 7th of January 2025; that is No Change since the beginning of the trading day. The stock's open price was 0.035.
With this module, you can estimate the performance of a buy and hold strategy of Appili Therapeutics and determine expected loss or profit from investing in Appili Therapeutics over a given investment horizon. Check out Appili Therapeutics Correlation, Appili Therapeutics Volatility and Appili Therapeutics Alpha and Beta module to complement your research on Appili Therapeutics.
Symbol

Appili Therapeutics Price To Book Ratio

Please note, there is a significant difference between Appili Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Appili Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Appili Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Appili Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Appili Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Appili Therapeutics.
0.00
12/08/2024
No Change 0.00  0.0 
In 31 days
01/07/2025
0.00
If you would invest  0.00  in Appili Therapeutics on December 8, 2024 and sell it all today you would earn a total of 0.00 from holding Appili Therapeutics or generate 0.0% return on investment in Appili Therapeutics over 30 days. Appili Therapeutics is related to or competes with Walmart, Amazon CDR, UPS CDR, HOME DEPOT, UnitedHealth Group, Berkshire Hathaway, and Costco Wholesale. Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for... More

Appili Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Appili Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Appili Therapeutics upside and downside potential and time the market with a certain degree of confidence.

Appili Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Appili Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Appili Therapeutics' standard deviation. In reality, there are many statistical measures that can use Appili Therapeutics historical prices to predict the future Appili Therapeutics' volatility.
Hype
Prediction
LowEstimatedHigh
0.000.048.98
Details
Intrinsic
Valuation
LowRealHigh
0.000.038.97
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Appili Therapeutics Backtested Returns

Appili Therapeutics appears to be out of control, given 3 months investment horizon. Appili Therapeutics secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of risk over the last 3 months. By analyzing Appili Therapeutics' technical indicators, you can evaluate if the expected return of 0.95% is justified by implied risk. Please makes use of Appili Therapeutics' Downside Deviation of 14.49, mean deviation of 6.07, and Risk Adjusted Performance of 0.0662 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Appili Therapeutics holds a performance score of 8. The firm shows a Beta (market volatility) of -0.74, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Appili Therapeutics are expected to decrease at a much lower rate. During the bear market, Appili Therapeutics is likely to outperform the market. Please check Appili Therapeutics' total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Appili Therapeutics' price patterns will revert.

Auto-correlation

    
  0.00  

No correlation between past and present

Appili Therapeutics has no correlation between past and present. Overlapping area represents the amount of predictability between Appili Therapeutics time series from 8th of December 2024 to 23rd of December 2024 and 23rd of December 2024 to 7th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Appili Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Appili Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test0.52
Residual Average0.0
Price Variance0.0

Appili Therapeutics lagged returns against current returns

Autocorrelation, which is Appili Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Appili Therapeutics' stock expected returns. We can calculate the autocorrelation of Appili Therapeutics returns to help us make a trade decision. For example, suppose you find that Appili Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Appili Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Appili Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Appili Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Appili Therapeutics stock over time.
   Current vs Lagged Prices   
       Timeline  

Appili Therapeutics Lagged Returns

When evaluating Appili Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Appili Therapeutics stock have on its future price. Appili Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Appili Therapeutics autocorrelation shows the relationship between Appili Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Appili Therapeutics.
   Regressed Prices   
       Timeline  

Pair Trading with Appili Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Appili Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Appili Therapeutics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Appili Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Appili Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Appili Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Appili Therapeutics to buy it.
The correlation of Appili Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Appili Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Appili Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Appili Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Appili Stock

Appili Therapeutics financial ratios help investors to determine whether Appili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.